IP Library Granted Patent US 11,781,160
Granted Patent B2
US 11,781,160 · App. 17/057,051 · Granted Oct 10, 2023

Methods for the production of methacrylates

Inventors: Zoe Disley (Nottingham, GB); Graham Ronald Eastham (Redcar, GB); David William Johnson (Redcar, GB); Laura Martins (Nottingham, GB); Russel Menchavez (Nottingham, GB); Luca Rossoni (Nottingham, GB); Gill Stephens (Nottingham, GB)
Assignee: Mitsubishi Chemical UK Limited
C12P7/62C12N1/38C12N15/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,781,160
App. No.
17/057,051
Granted
Oct 10, 2023
Kind
B2
Abstract

The invention relates to methods for the production of methacrylates using methacrylate tolerant microorganisms.

Claims (32)

1. A method for the production of a methacrylate comprising

a) providing a genetically modified microorganism with increased tolerance to a C 3 -C 12 methacrylate ester compared to the wild type microorganism in a fermentation medium and

b) growing the microorganism under conditions whereby a C 3 -C 12 methacrylate ester is produced;

wherein the microorganism is E coli;

wherein the genetically modified microorganism comprises a mutation in a wild type soxR nucleic acid sequence;

wherein the wild type soxR nucleic acid sequence comprises SEQ ID NO. 1 or a homologue thereof, and

wherein the mutant soxR nucleic acid sequence encodes a mutant SoxR protein comprising R20 substituted with H.

2. The method according to claim 1 wherein the microorganism is tolerant to at least 20% v/v C 3 -C 12 methacrylate ester when grown in a liquid medium at about 37° C.

3. The method according to claim 1 wherein the genetically modified microorganism further comprises a mutation in one or more of:

an acrR nucleic acid sequence comprising SEQ ID NO. 3 or a homologue thereof, a rob nucleic acid sequence comprising SEQ ID NO. 5 or a homologue thereof, a marR nucleic acid sequence comprising SEQ ID NO. 7 or a homologue thereof.

4. The method according to claim 3 , wherein the mutant acrR nucleic acid sequence encodes a mutant AcrR protein, and wherein the mutation is selected from one of the following: a substitution of V29 with another amino acid, a frameshift mutation at T32, A191 or position 49 in AcrR.

5. A method for growing or maintaining a microorganism in the presence of a C 3 -C 12 methacrylate ester comprising providing a genetically modified microorganism with increased tolerance to a C 3 -C 12 methacrylate ester compared to a wild type microorganism in a fermentation medium under conditions whereby a C 3 -C 12 methacrylate ester is produced,

wherein the microorganism is E coli;

wherein the genetically modified microorganism comprises a mutation is in a wild type soxR nucleic acid sequence;

wherein the wild type soxR nucleic acid sequence comprises SEQ ID NO. 1 or a homologue thereof; and

wherein the mutant soxR nucleic acid sequence encodes a mutant SoxR protein comprising R20 substituted with H.

6. A fermentation medium comprising a C 3 -C 12 methacrylate ester and a genetically modified microorganism with increased tolerance to a C 3 -C 12 methacrylate ester compared to a wild type microorganism;

wherein the microorganism is E. coli;

wherein the genetically modified microorganism comprises a mutation is in a wild type soxR nucleic acid sequence;

wherein the wild type soxR nucleic acid sequence comprises SEQ ID NO. 1 or a homologue thereof; and

wherein the mutant soxR nucleic acid sequence encodes a mutant SoxR protein comprising R20 substituted with H.

7. A method for the isolation of a methacrylate tolerant microorganism comprising:

a) providing a microorganism in a fermentation medium

b) contacting the microorganism with a methacrylate; and

c) isolating the viable microorganism of step (b)

wherein the viable microorganism is tolerant to at least 20% v/v a methacrylate when grown in liquid medium at about 37° C.

wherein the microorganism is E coli;

wherein the microorganism comprises a mutation in a wild type soxR nucleic acid sequence;

wherein the wild type soxR nucleic acid sequence comprises SEQ ID NO. 1 or a homologue thereof; and

wherein the mutant soxR nucleic acid sequence encodes a mutant SoxR protein comprising R20 substituted with H.

8. The method according to claim 3 , wherein the mutant rob nucleic acid sequence encodes a mutant Rob protein, and wherein the mutation is selected from one of the following: a substitution of A70 or a substitution of R156 with another amino acid in Rob.

9. The method according to claim 3 , wherein the mutant marR nucleic acid sequence encodes a mutant MarR protein, and wherein the mutation is a substitution of V84 with another amino acid in MarR.

Assignments (3)
CHANGE OF NAME Recorded Apr 27, 2021
From: LUCITE INTERNATIONAL UK LIMITED
To: MITSUBISHI CHEMICAL UK LIMITED
Reel/Frame 057269/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2021
From: DISLEY, ZOE; EASTHAM, GRAHAM RONALD; JOHNSON, DAVID WILLIAM; MARTINS, LAURA; MENCHAVEZ, RUSSEL; ROSSONI, LUCA; STEPHENS, GILL
To: MITSUBISHI CHEMICAL UK LIMITED
Reel/Frame 055477/0099 →
CHANGE OF NAME Recorded Feb 1, 2021
From: LUCITE INTERNATIONAL UK LIMITED
To: MITSUBISHI CHEMICAL UK LIMITED
Reel/Frame 055099/0488 →
Priority Claims (1)
GB 1808424 · May 23, 2018 · national
Continuity (1)
Related Publication 20210207177A1 · Jul 8, 2021